Cube Biotech company information, Employees & Contact Information

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors Biotech Newswire

Cube Biotech and X-Chem Partner to Enable DNA-encoded GlobeNewswire

Cube Biotech Appoints Michael Bencak Chief Executive Officer Contract Pharma

Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration PR Newswire

Former Sartorius boss leads class of biotech executive shakeups BioProcess International

Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans Pharmafile

Archimed-backed Cube Biotech buys IBA Lifesciences pehub.com

Cube Biotech acquires IBA Lifesciences Indian Pharma Post

Genmab pays $8B to buy Merus and its phase 3 bispecific that wowed analysts Fierce Biotech

Cube Biotech Acquires IBA Lifesciences Contract Pharma

Cube Biotech appoints Joachim Kreuzburg to its board of directors Pharmafile

ASCO: Cullinan, Taiho unveil lung cancer data behind FDA application plans Fierce Biotech

Momentum Biotechnologies and Cube Biotech Announce Strategic Partnership PR Newswire

Gilead culls Novo-partnered MASH candidate and 2 cancer assets Fierce Biotech

Momentum, Cube Biotech Enter Strategic Pact Contract Pharma

Delivering the Future of Radiopharmaceuticals with Precision Fierce Biotech

Embattled Elevation becomes latest biotech to accept Concentra buyout offer Fierce Biotech

'I don't feel we lost momentum': Takeda’s oncology execs sharpen focus after restructuring Fierce Biotech

Biotech's contract terminated in HHS mRNA vaccine rollback doesn't involve mRNA or vaccines Fierce Biotech

M&A remains ‘top priority’ for Big Pharmas in the face of tariff threat Fierce Biotech

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine Yahoo Finance

EXCLUSIVE: Case study: C-CUBE's first biotech modular project in Europe Cleanroom Technology

Novo Nordisk's new Boston-area campus reflects 'competitive' R&D growth, and not just for GLP-1s Fierce Biotech

Research non-profit to acquire embattled Essa in Xoma Royalty-backed deal Fierce Biotech

Boehringer Ingelheim drops obesity drug from Gubra partnership Fierce Biotech

Acelyrin to be absorbed into Alumis in all-stock merger Fierce Biotech

Amicus pays Dimerix $30M for late-phase rare kidney disease drug Fierce Biotech

Roivant's FcRn inhibitor avoids cholesterol problem, which clouded CEO Matt Gline's first days in the gig Fierce Biotech

Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset Fierce Biotech

Otsuka pays $800M for Jnana Therapeutics and its clinical-stage PKU drug Fierce Biotech

In struggling Hepion, Israeli biotech spies path to go public before seeking FDA approval Fierce Biotech

While FDA mulls Zevra's rare disease med, Rafael merges with Cyclo to push their rival candidate Fierce Biotech

UPDATE: Magenta cuts 14% of staff, trims R&D amid tumultuous biotech markets Fierce Biotech

After 'live fire exercise' with COVID-19, SAB turns tactical experience back to diabetes program Fierce Biotech

Merck & Co. signs $208M deal to acquire startup in bid to improve ADC safety Fierce Biotech

Roche drops HER2 bispecific, Xencor-partnered cytokine from early-phase pipeline Fierce Biotech

45 days later, BioCryst abandons another program, citing stiff competition Fierce Biotech

Ideaya, eyeing drug combos, bags option on Biocytogen bispecific ADC in $400M deal Fierce Biotech

AnaptysBio scraps atopic dermatitis asset after antibody fails to meet all endpoints in ph. 2 Fierce Biotech

N-Power links up with Syapse to add oncologists to clinical research network Fierce Biotech

Regeneron touts possible 'best-in-class' myeloma bispecific, but adverse events climb to 100% Fierce Biotech

AstraZeneca melds with Fusion in $2B radiopharma buyout Fierce Biotech

NAYA buys Florida Biotechnologies for $20M to get hold of rare genetic disease drug Fierce Biotech

AbbVie pads neuroscience portfolio with $8.7B deal to acquire Cerevel Fierce Biotech

Radiopharma-focused Pentixapharm picks up Glycotope's discovery unit for preclinical cancer antibodies Fierce Biotech

PharmaCyte forced to think outside the box as CEO departs amid ongoing clinical hold Fierce Biotech

BMS pays $800M upfront for antibody-drug conjugate, opening new front in Merck rivalry Fierce Biotech

Polymer-Encased Nanodiscs and Polymer Nanodiscs: New Platforms for Membrane Protein Research and Applications Frontiers

GLP-1 drug hydrogels could reduce shots to once every 4 months Fierce Biotech

High-tech's business model hasn't worked for the Cue COVID test Fierce Biotech

Adial at a clinical fork in the road after flunking phase 3 trial for its alcohol addiction med Fierce Biotech

Tasso earns FDA clearance for its home blood collection device for telehealth tests Fierce Biotech